Siemens Healthineers: Jefferies starts tracking with a buy recommendation

(CercleFinance.com) - On Thursday, Jefferies began tracking Siemens Healthineers shares with a buy recommendation and a price target of 60 euros, indicating a potential upside of 17%.


In a study of European medtech players, the analyst praises the German group's positioning in the high-growth markets of imaging and radiotherapy.

Jefferies points out that the medical imaging sector has so far proved particularly resilient during economic downturns.

If its research is to be believed, Siemens Healthineers should even continue to win market share.

In its note, the intermediary believes that the company's management team has won the confidence of investors since the IPO in March 2018, with the exception of the diagnostics division.

According to Jefferies, a disposal of the latter division could, however, create more value, provided the business is successfully restructured.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.